Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPERIDINE vs MEROPENEM ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPERIDINE vs MEROPENEM ANHYDROUS: Safety Overview

Metric MEPERIDINE MEROPENEM ANHYDROUS
Total FAERS Reports 6,404 144
Deaths Reported 466 25
Death Rate 7.3% 17.4%
Hospitalizations 551 102
Average Patient Age 57.5 yrs 55.0 yrs
% Female Patients 68.1% 44.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Mylan Institutional LLC
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued N/A